Race Oncology (ASX:RAC) has completed its Phase 1b/2 trial of bisantrene in combination with clofarabine and fludarabine for ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

BioLineRx Ltd. (NASDAQ/TASE: BLRX), a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today announced that it has received a Notice of ...

Women, girls, and other vulnerable groups are more likely to be exposed to and impacted by toxic substances – including lead, ...

With a new four-year, $1.3 million grant from the U.S. Department of Veterans Affairs, researchers at Case Western Reserve ...